Latest News
Karman Shares Surge Then Slide as Earnings Confirm High Expectations
Karman Holdings shares surged 6.2% then tumbled 11% after hours as Q1 earnings met estimates but high expectations and contingent orders raised caution.
Velo3D Surges 25% on Q1 Beat, Margin Improvement
Velo3D shares surged 24.7% in after-hours trading after Q1 revenue rose 48% to $13.8 million and gross margin improved to 17.2%. The company maintains its positive EBITDA guidance for late 2026.
Rackspace Surges 35% on AI Cloud Deal with AMD, Short Squeeze Amplifies Rally
Rackspace Technology shares surged 35% after announcing an AI cloud deal with AMD, with short covering amplifying the move as trading volume tripled.
OpenEvidence Partners with SSO, Pushes AI Deeper into Cancer Surgery
OpenEvidence partners with the Society of Surgical Oncology to integrate clinical content into its AI platform and launch a $100,000 grant for surgeon-led research.
Nextpower Surges After Q4 Beat, Raised Guidance Boosts Platform Narrative
Nextpower shares surged 10% after hours following Q4 results that topped estimates and a raised fiscal 2027 revenue outlook, fueling investor confidence in its platform expansion.
United Flight Attendants Ratify Deal with 31% Pay Hike and Boarding Compensation
United Airlines flight attendants ratified a five-year contract with a 31% base-pay increase, boarding pay, and $741 million in retroactive wages, ending a lengthy negotiation.
Oklo Shares Slide as Q1 Loss Triples, Cash Hoard Tops $2.5 Billion
Oklo reported a Q1 net loss of $33.1 million, more than triple last year, as R&D and admin costs surged. The company holds $2.54 billion in cash but has no reactor revenue.
QuantumScape Surges on $11M Billings, Eagle Line Progress
QuantumScape shares gained 4.9% Tuesday after reporting $11M in Q1 customer billings and progress at its Eagle Line pilot facility, signaling a step toward commercial solid-state battery production.
SELLAS Stock Surges as REGAL Trial Nears Final Analysis
SELLAS Life Sciences shares rose after hours as its REGAL leukemia trial recorded 78 of 80 events needed for final analysis. The company reported a Q1 net loss of $8.4 million but has $107.1 million in cash.
BAT Shares Surge on FDA Policy Shift and Legal Resolution
British American Tobacco shares rose 5.82% in London after the FDA signaled a softer stance on e-cigarette enforcement and a U.S. judge dismissed a North Korea sanctions case.
